Hemophilia A (anti-hemophilic globulin deficiency) is transmitted as an incompletely recessive trait on the X chromosome. Therefore, the daughter of a hemophiliac must be a carrier. In contrast, the daughter of a carrier, e.g., the sister of a hemophiliac, is a "potential" carrier who has an equal chance of being either a carrier or normal. She doesn't know which she is until she bears a hemophilic son; it requires this event to identify her as a known or "obligatory" carrier.
The dilemma of the potential carrier has prompted many investigators to look for some clotting abnormality which might identify a carrier. Nilsson (2) . They found low AHG levels in six of ten carriers of mild hemophilia and thought this was a peculiarity of the allelic mutant of the hemophilic gene responsible for mild hemophilia. In apparent confirmation, Gardikas, Katsiroumbas and Kottas (3) reported normal AHG levels in ten obligatory carriers of severe hemophilia. However, several subsequent groups of workers (4) (5) (6) demonstrated diminished levels of AHG in some carriers of both mild and severe hemophilia; and, recently, Nilsson and co-workers (1) reported that the vast majority of carriers have low levels of AHG.
The present paper reports on quantitative measurements of AHG made with the Pool-Robinson AHG assay technique (7) in a large number of obligatory carriers and normal women. Douglas and Cook (10) , and by McGovern and Steinberg (11) .
The carrier in our series with 22 per cent AHG had bled on the tenth day after tonsillectomy, for three days after one tooth extraction, and for seven days after another. She had developed massive ecchymoses following a minor injury to her leg. Her well documented family history of hemophilia, which followed a sex-linked recessive pattern over several generations, coupled with her normal bleeding time leaves little doubt that she represents another example of significant bleeding in a heterozygous carrier and not of vascular hemophilia.
This carrier comes from a kindred with mild hemophilia (AHG levels of 15 to 20 per cent in affected males). It is of interest that the carriers described by Douglas and Cook (10) grounds, then the mean shown in Figure 3 would remain essentially unchanged, but the variances of the carrier and normal groups would become more nearly equal. This would alter slightly the data shown in Figures 4 and 5 (see below) . However, in view of the scantiness at present of the evidence for a separate carrier population, we have considered her as an ordinary carrier in our statistical calculations.
Seven of our carriers had AHG levels between 30 and 40 per cent. None had bled abnormally despite the fact that all had had teeth extracted and many had been through major surgery. This is indirect evidence that AHG levels above 30 per cent are usually adequate for hemostasis.
C. Recognition of the carrier by AHG assay. Since the daughter of a carrier has an equal chance of being either normal or a carrier, the accumulated frequencies shown in Figure 3 may be used to calculate her chances of being a true carrier at or below any observed AHG level. This is shown in Figure 4 . Although each laboratory uses a different 100 per cent reference plasma, the value for the mean of a normal population will probably be found within the limits of 90 to 110 per cent of the particular reference plasma, respectively. Linear interpolation between these curves is probably adequate for practical purposes. Therefore, once the normal mean for a reference plasma has been established, Figure 4 may be used to estimate the probability that a potential carrier may be a true carrier at or below any observed per cent AHG of that reference plasma. The mean of our carrier series was 58 per cent AHG. Figure 4 shows that 95 of 100 potential carriers with an AHG level equal to or below 58 per cent of our reference standard will be true carriers. Approximately three-fourths of our carriers had AHG levels below 70 per cent. From line A of Figure 4 we see that a potential carrier with an AHG level at or below 70 per cent of our reference standard has better than four chances out of five of being a true carrier. Thus, it would appear that AHG assay by the thromboplastin generation technique enables one to recognize with reasonable accuracy about 75 per cent of the true carriers in a potential carrier population.
In a similar fashion it is possible to estimate the probabilities that a potential carrier may be normal when her AHG level equals or exceeds any observed value. This is shown in Figure 5 .
As seen from line A of Figure 5 4. Probability calculations indicate that this AHG assay will detect with reasonable accuracy (four chances out of five) about 75 per cent of the true carriers in a potential carrier population and about 66 per cent of the normal members in a potential carrier population. However, a potential carrier with even a very high AHG level still retains one chance in five of being a true carrier.
